SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share buyback programme

15 Apr 2026 13:19

RNS Number : 6225A
Rotork PLC
15 April 2026
 

Rotork plc

Share buyback programme - Tranche 5

15 April 2026

 

Consistent with our stated capital allocation policy, Rotork completed the first tranche of its £50m share buyback programme (the 'Programme') on 19 December 2025, the second and third tranches on 6 March 2026, and the fourth tranche on 10 April 2026. Our financial flexibility enables us to pursue strategic investments and we remain active in looking for suitable opportunities, consistent with our Growth+ strategy.

 

The fifth tranche of the Programme will be carried out through an irrevocable non-discretionary agreement with J.P. Morgan Securities plc ('JPM'), pursuant to which JPM shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The fifth tranche of the Programme will run from 15 April 2026 and end no later than 15 May 2026. The aggregate purchase price of all Ordinary Shares acquired under the fifth tranche of the Programme will be no greater than £10 million (excluding stamp duty and expenses). Any Ordinary Shares purchased by the Company will be cancelled. Any purchases under the Programme will take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted at the Company's 2025 Annual General Meeting (the '2025 Authority') and any subsequent authority granted at the Company's next Annual General Meeting. The maximum number of Ordinary Shares that the Company remains authorised to purchase under the 2025 Authority is 59,186,120 Ordinary Shares. JPM will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company.

 

Any purchase of Ordinary Shares under the fifth tranche of the Programme will be carried out on the London Stock Exchange and CBOE Europe Limited, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its 2025 Annual General Meeting, Chapter 9 of the UK Financial Conduct Authority's UK Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares by no later than the end of the 7th daily market session following the date of execution of such purchases, in accordance with UKLR 9.6.6.

 

 

 

Enquiries to:

 

Alex Toms, Investor Relations Director Tel: +44 (0) 1225 733 200

Stuart Pain, Group General Counsel & Company Secretary, Rotork plc Tel: +44 (0) 1225 733 200

Nick Hasell/Edward Knight, FTI Consulting Tel: +44 (0) 20 3727 1340

 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFAFEIEMSEFL
Date   Source Headline
2nd Jul 202011:27 amRNSTotal Voting Rights
30th Jun 20207:00 amRNSPre-close update
12th Jun 20209:28 amRNSDirector/PDMR Shareholding
4th Jun 202010:33 amRNSTotal Voting Rights
1st Jun 20204:00 pmRNSDirector/PDMR Shareholding
22nd May 20204:07 pmRNSDirector/PDMR Shareholding
13th May 20203:47 pmRNSDirector/PDMR Shareholding
13th May 20209:35 amRNSDisclosure of rights attached to equity shares
1st May 20208:10 amRNSTotal Voting Rights
24th Apr 20201:34 pmRNSResult of AGM
17th Apr 20203:13 pmRNSAnnual General Meeting 2020 Update
15th Apr 20204:50 pmRNSDirector/PDMR Shareholding
9th Apr 20202:14 pmRNSHolding(s) in Company
9th Apr 202012:54 pmRNS2020 LTIP awards and Remuneration Update
6th Apr 202010:08 amRNSCompany Secretary Change
3rd Apr 202011:36 amRNSDirector Declaration
2nd Apr 20205:18 pmRNSTotal Voting Rights
2nd Apr 20205:08 pmRNSHolding(s) in Company
1st Apr 20209:00 amRNSNotice of AGM
31st Mar 20207:00 amRNSResponding to COVID-19
17th Mar 20205:07 pmRNSDirector/PDMR Shareholding
13th Mar 20203:56 pmRNSDirector/PDMR Shareholding
12th Mar 20203:05 pmRNSDirector/PDMR Shareholding
11th Mar 20204:55 pmRNSDirector/PDMR Shareholding
6th Mar 20204:30 pmRNSHolding(s) in Company
4th Mar 20203:29 pmRNSDirector Declaration
4th Mar 20207:00 amRNSHolding(s) in Company
3rd Mar 20201:30 pmRNSTotal Voting Rights
3rd Mar 20207:00 amRNS2019 Full Year Results
28th Feb 20208:14 amRNSDirector Declaration
14th Feb 20203:14 pmRNSDirector/PDMR Shareholding
3rd Feb 20201:17 pmRNSTotal Voting Rights
13th Jan 20203:05 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:09 amRNSTotal Voting Rights
20th Dec 20192:39 pmRNSDirector/PDMR Shareholding
20th Dec 201912:41 pmRNSDirector/PDMR Shareholding
2nd Dec 20195:02 pmRNSTotal Voting Rights
21st Nov 20192:05 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSTrading Update
14th Nov 201910:07 amRNSHolding(s) in Company
13th Nov 201910:39 amRNSDirector/PDMR Shareholding
6th Nov 20194:13 pmRNSHolding(s) in Company
5th Nov 20197:30 amRNSDirector Declaration
1st Nov 20191:44 pmRNSTotal Voting Rights
21st Oct 20191:36 pmRNSDirector/PDMR Shareholding
15th Oct 20193:53 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSTotal Voting Rights
30th Sep 201911:28 amRNSDirector Declaration
23rd Sep 201910:58 amRNSDirector/PDMR Shareholding
13th Sep 20193:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.